Celcuity, Inc. (CELC)
92.20
+1.41
(+1.55%)
USD |
NASDAQ |
Aug 25, 16:00
92.20
0.00 (0.00%)
After-Hours: 19:59
Celcuity 1 Year Total Returns (Daily) : 73.20% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 73.20% |
| August 21, 2026 | 85.65% |
| August 20, 2026 | 85.71% |
| August 19, 2026 | 90.27% |
| August 18, 2026 | 80.80% |
| August 17, 2026 | 78.49% |
| August 14, 2026 | 77.30% |
| August 13, 2026 | 65.36% |
| August 12, 2026 | 83.94% |
| August 11, 2026 | 88.83% |
| August 10, 2026 | 97.89% |
| August 07, 2026 | 109.7% |
| August 06, 2026 | 111.0% |
| August 05, 2026 | 116.9% |
| August 04, 2026 | 114.4% |
| August 03, 2026 | 119.8% |
| July 31, 2026 | 120.6% |
| July 30, 2026 | 117.5% |
| July 29, 2026 | 116.3% |
| July 28, 2026 | 124.1% |
| July 27, 2026 | 497.5% |
| July 24, 2026 | 488.0% |
| July 23, 2026 | 528.8% |
| July 22, 2026 | 546.6% |
| July 21, 2026 | 577.2% |
| Date | Value |
|---|---|
| July 20, 2026 | 547.5% |
| July 17, 2026 | 542.8% |
| July 16, 2026 | 537.0% |
| July 15, 2026 | 564.1% |
| July 14, 2026 | 707.6% |
| July 13, 2026 | 661.5% |
| July 10, 2026 | 689.9% |
| July 09, 2026 | 740.2% |
| July 08, 2026 | 712.7% |
| July 07, 2026 | 767.5% |
| July 06, 2026 | 687.4% |
| July 02, 2026 | 727.8% |
| July 01, 2026 | 736.6% |
| June 30, 2026 | 683.7% |
| June 29, 2026 | 717.5% |
| June 26, 2026 | 732.2% |
| June 25, 2026 | 709.5% |
| June 24, 2026 | 693.3% |
| June 23, 2026 | 687.9% |
| June 22, 2026 | 675.3% |
| June 18, 2026 | 643.1% |
| June 17, 2026 | 647.5% |
| June 16, 2026 | 600.8% |
| June 15, 2026 | 628.7% |
| June 12, 2026 | 605.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cogent Biosciences, Inc. | 198.9% |
| Replimune Group, Inc. | 159.4% |
| Erasca, Inc. | 1.00K% |
| Apogee Therapeutics, Inc. | 252.2% |
| Arrowhead Pharmaceuticals, Inc. | 306.6% |